Exact Mass: 616.4339

Exact Mass Matches: 616.4339

Found 58 metabolites which its exact mass value is equals to given mass value 616.4339, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tsugarioside B

[4,4,10,13,14-pentamethyl-17-[6-methyl-1-(3,4,5-trihydroxyoxan-2-yl)oxyhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

C37H60O7 (616.4339)


Tsugarioside B is found in mushrooms. Tsugarioside B is a constituent of Ganoderma tsugae (red reishi) Constituent of Ganoderma tsugae (red reishi). Tsugarioside B is found in mushrooms.

   

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

(2S)-3-(dodecanoyloxy)-2-hydroxypropyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-3-(dodecanoyloxy)-2-hydroxypropyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C37H60O7 (616.4339)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

argentinic acid A methyl ester

argentinic acid A methyl ester

C37H60O7 (616.4339)


   

Inundoside B

Inundoside B

C37H60O7 (616.4339)


   

cholest-14-ene-3,7,24,25-tetrol-21,23-epoxy-21-methoxy-4,4,8-trimethyl-3-(3-methyl-2-butenoate)

cholest-14-ene-3,7,24,25-tetrol-21,23-epoxy-21-methoxy-4,4,8-trimethyl-3-(3-methyl-2-butenoate)

C37H60O7 (616.4339)


   

Tsugarioside B

2,6,6,11,15-pentamethyl-14-{6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-5-yl acetate

C37H60O7 (616.4339)


   

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/12:0/0:0)

C37H60O7 (616.4339)


   

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/12:0)

C37H60O7 (616.4339)


   

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/12:0/0:0)

C37H60O7 (616.4339)


   

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/12:0)

C37H60O7 (616.4339)


   

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(i-12:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-12:0/0:0)

C37H60O7 (616.4339)


   

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(i-12:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C37H60O7 (616.4339)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-12:0)

C37H60O7 (616.4339)


   

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(i-12:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-12:0/0:0)

C37H60O7 (616.4339)


   

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(i-12:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C37H60O7 (616.4339)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-12:0)

C37H60O7 (616.4339)


   

2-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[2-heptanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H63NO7P+ (616.4342)


   

(3s,3as,5ar,6r,7r,9r,9ar)-7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl (2r,3r)-2-hydroxy-3-methylpentanoate

(3s,3as,5ar,6r,7r,9r,9ar)-7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl (2r,3r)-2-hydroxy-3-methylpentanoate

C37H60O7 (616.4339)


   

3-hydroxy-15-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

3-hydroxy-15-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)


   

3a,6,6,9a,11a-pentamethyl-1-{6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

3a,6,6,9a,11a-pentamethyl-1-{6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

[(2r)-5-oxo-1,4-dioxacyclooctacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(2r)-5-oxo-1,4-dioxacyclooctacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C37H60O7 (616.4339)


   

7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl 2-hydroxy-3-methylpentanoate

7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl 2-hydroxy-3-methylpentanoate

C37H60O7 (616.4339)


   

(1r,3ar,5as,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2s,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3ar,5as,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2s,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)


   

(5-oxo-1,4-dioxacyclooctacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(5-oxo-1,4-dioxacyclooctacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C37H60O7 (616.4339)


   

1,7,7,11,16,20,20-heptamethyl-19-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

1,7,7,11,16,20,20-heptamethyl-19-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C37H60O7 (616.4339)


   

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3ar,5ar,7r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-1-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C37H60O7 (616.4339)


   

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-hydroxy-15-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)


   

(1r,3s,3ar,5ar,7r,9as,11ar)-3-hydroxy-1-[(2r)-1-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl 1-methyl (3s)-3-hydroxy-3-methylpentanedioate

(1r,3s,3ar,5ar,7r,9as,11ar)-3-hydroxy-1-[(2r)-1-hydroxy-6-methylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl 1-methyl (3s)-3-hydroxy-3-methylpentanedioate

C37H60O7 (616.4339)


   

(1s,6r,8s,11r,12s,15s,16r,19s,21r)-1,7,7,11,16,20,20-heptamethyl-19-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

(1s,6r,8s,11r,12s,15s,16r,19s,21r)-1,7,7,11,16,20,20-heptamethyl-19-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-yl acetate

C37H60O7 (616.4339)


   

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-3-hydroxy-15-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C37H60O7 (616.4339)